经导管与外科主动脉瓣置换术后人工瓣膜心内膜炎
基于STS数据库2011至2021年因TAVR或SAVR后活动性人工瓣膜心内膜炎再手术的6257例患者(TAVR 374例,SAVR 5883例),TAVR组主动脉根部修复较少(24.9% vs 34.8%,P<.001),总体手术死亡率无显著差异(13.6% vs 10.8%,P=.088),风险调整后既往TAVR与手术死亡率无关(OR 0.99,95%CI 0.72-1.38)。
要点
- TAVR后PVE再手术量从2011年1例增至2020年116例。
- TAVR组较SAVR组主动脉根部修复少(24.9% vs 34.8%,P<.001)。
- 风险调整后既往TAVR与手术死亡率无关(OR 0.99,95%CI 0.72-1.38)。
核心结论
- TAVR后主动脉根部修复较SAVR后少见,且既往TAVR与手术死亡率增加无关。
- 在STS索引手术(SAVR±冠状动脉旁路移植术)亚组中,TAVR后设置与较高死亡率相关。
研究设计与样本
- 使用胸外科医师学会(STS)数据库查询2011至2021年因TAVR和SAVR后活动性人工瓣膜心内膜炎再手术的患者。
- 共纳入6257例患者,其中TAVR 374例(6%),SAVR 5883例(94%)。
主要发现
- TAVR后病例量从2011年1例增至2020年116例。
- 与SAVR组相比,TAVR组年龄更大、既往起搏器更常见、主动脉根部脓肿更少。
- 术中TAVR组接受主动脉根部修复较少(24.9% vs 34.8%,P<.001),体外循环和主动脉阻断时间更短。
- 全体患者中,TAVR组手术死亡率为13.6%,SAVR组为10.8%(P=.088)。
- 风险调整后,既往TAVR本身与手术死亡率无关(OR 0.99,95%CI 0.72-1.38)。
关键数值与推荐
- TAVR组主动脉根部修复率24.9% vs SAVR组34.8%(P<.001)。
- 全体患者手术死亡率TAVR组13.6% vs SAVR组10.8%(P=.088)。
- 风险调整后既往TAVR与手术死亡率OR 0.99(95%CI 0.72-1.38)。
- STS索引手术亚组死亡率TAVR后14.3% vs SAVR后7.9%(P=.005),观察与预期死亡率比值分别为2.2和1.3。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prosthetic valve endocarditis (PVE) is a devastating sequela of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). However, reoperation for post-TAVR PVE is not well described. We investigated the implications of surgically managed PVE after TAVR and SAVR. METHODS: Reoperations for active PVE after TAVR and SAVR from 2011 to 2021 were queried using The Society of Thoracic Surgeons (STS) database. We identified 6257 patients, consisting of 374 TAVR (6%) and 5883 SAVR recipients (94%). RESULTS: Post-TAVR case volume increased from 1 in 2011 to 116 in 2020. Compared with SAVR, the TAVR group was associated with older age, more frequent preexisting pacemaker, and fewer aortic root abscesses. Intraoperatively, TAVR patients received less aortic root repair (24.9% vs 34.8%; P < .001) and had shorter cardiopulmonary bypass/aortic cross-clamp times. Among all comers, the operative mortality in patients with previous was 13.6% for TAVR vs 10.8% for SAVR (P = .088). After risk adjustment, previous TAVR itself was not associated with operative mortality (odds ratio, 0.99; 95% CI, 0.72-1.38). In contrast, among 154 post-TAVR and 2232 post-SAVR patients with STS-indexed procedures (SAVR ± coronary artery bypass grafting) with available STS predicted risk of mortality, the mortality was 14.3% and 7.9% (P = .005), with corresponding observed-to-expected mortality ratio of 2.2 and 1.3, respectively. CONCLUSIONS: Aortic root repair was seen less frequently after TAVR than after SAVR. Furthermore, previous TAVR was not associated with increased operative mortality. In contrast, the post-TAVR setting was associated with higher mortality regarding isolated SAVR or SAVR plus coronary artery bypass grafting.
引用
- Fukuhara S, Wu X, Hawkins R, et al. Prosthetic Valve Endocarditis After Transcatheter and Surgical Aortic Valve Replacement. Ann Thorac Surg. 2023. PMID: 37121292. doi:10.1016/j.athoracsur.2023.03.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。